Screening for type 2 diabetes mellitus
Little information is available about harms of screening, although several harms are potentially serious problems. The costs of diagnosis, treatment, and dealing with the complications of DM-2 are high. One study examined the cost-effectiveness of screening for DM-2 but assumed that the only effecti...
| Main Author: | |
|---|---|
| Corporate Authors: | , , |
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Rockville (MD)
Agency for Healthcare Research and Quality (US)
2003, [2003]
|
| Series: | Systematic evidence reviews
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references